510(k) and CE Clearance For Iridex Laser Delivery System

Iridex Corporation has gained FDA 510(k) and CE clearance of the TxCell Scanning Laser Delivery System which it says saves significant time in a variety of laser photocoagulation procedures in allowing physicians to deliver the laser in a multi-spot scanning mode, rather than the traditional single spot mode.



IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases (via PR Newswire)

MOUNTAIN VIEW, Calif., Dec. 3, 2012 /PRNewswire/ — IRIDEX Corporation (NASDAQ: IRIX) today announced the FDA 510(k) and CE clearance of the TxCell Scanning Laser Delivery System.  The new product saves significant time in a variety of laser photocoagulation procedures in allowing physicians to…


published: December 11, 2012 in: Approval/Clearance, Ophthalmics

Most read

Latest

^